Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Indinavir concentrations and antiviral effect
Edward P. Acosta
, Keith Henry
, Leslie Baken
, Linda M. Page
, Courtney V. Fletcher
Research output
:
Contribution to journal
›
Article
›
peer-review
156
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Indinavir concentrations and antiviral effect'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antiviral Activity
100%
Indinavir
100%
Concentration Effect
100%
AIDS/HIV
63%
Virus RNA
45%
Protease Inhibitors
27%
Pharmacokinetics
18%
Pharmacologic
18%
Plasma Concentration
9%
Clinical Research Center
9%
Therapeutic Response
9%
Oral Dose
9%
Virologic
9%
Systemic Exposure
9%
MRNA Level
9%
Area under the Curve
9%
Pharmacokinetic Parameters
9%
One-compartment
9%
Outpatient Clinic
9%
University-affiliated
9%
Nucleoside Reverse Transcriptase Inhibitors
9%
Oral Clearance
9%
Concentration of Measure
9%
Oral Absorption
9%
Pharmacokinetic Evaluation
9%
Inter-subject Variability
9%
Oral Pharmacokinetics
9%
Dose Parameter
9%
Exposure Effects
9%
Virus Effects
9%
Absorption Model
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
Indinavir
100%
HIV
54%
Virus RNA
45%
Proteinase Inhibitor
27%
Pharmacokinetics
27%
Anti-Human Immunodeficiency Virus
9%
Clinical Research
9%
Pharmacokinetic Parameter
9%
RNA Directed DNA Polymerase Inhibitor
9%
Neuroscience
Indinavir
100%
Human Immunodeficiency Virus
63%
Blood Plasma
45%
Pharmacokinetics
36%
Proteinase
27%
Reverse-Transcriptase Inhibitor
9%